Functional assessment of two variants of unknown significance in TEK by endothelium-specific expression in zebrafish embryos.

Bell, Lorenz M; Holm, Annegret; Matysiak, Uta; Driever, Wolfgang; Rössler, Jochen; Schanze, Denny; Wieland, Ilse; Niemeyer, Charlotte M; Zenker, Martin; Kapp, Friedrich G (2021). Functional assessment of two variants of unknown significance in TEK by endothelium-specific expression in zebrafish embryos. Human molecular genetics, 31(1), pp. 10-17. Oxford University Press 10.1093/hmg/ddab196

Full text not available from this repository. (Request a copy)

Vascular malformations are most often caused by somatic mutations of the PI3K/mTOR and the RAS signaling pathways, which can be identified in the affected tissue. Venous malformations commonly harbor PIK3CA and TEK mutations, whereas arteriovenous malformations are usually caused by BRAF, RAS, or MAP2K1 mutations. Correct identification of the underlying mutation is of increasing importance, since targeted treatments are becoming more and more relevant, especially in patients with extensive vascular malformations. However, variants of unknown significance are often identified and their pathogenicity and response to targeted therapy cannot be precisely predicted. Here we show, that zebrafish embryos can be used to rapidly assess the pathogenicity of novel variants of unknown significance in TEK, encoding for the receptor TIE2, present on endothelial cells of venous malformations. Endothelium-specific overexpression of TEK mutations leads to robust induction of venous malformations whereas MAP2K1 mutations cause arteriovenous malformations in our zebrafish model. TEK mutations are often found as double mutations in cis; using our model, we show that double mutations have an additive effect in inducing venous malformations compared to the respective single variants. The clinically established mTOR-inhibitor sirolimus (rapamycin) efficiently abrogates the development of venous malformations in this zebrafish model. In summary, endothelium-specific overexpression of patient-derived TEK variants in the zebrafish model allows assessment of their pathogenic significance as well as testing of candidate drugs in a personalized and mutation-specific approach.

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine 04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Paediatric Haematology/Oncology
UniBE Contributor:	Rössler, Jochen Karl
Subjects:	600 Technology > 610 Medicine & health
ISSN:	0964-6906
Publisher:	Oxford University Press
Language:	English
Submitter:	Anette van Dorland
Date Deposited:	29 Aug 2021 23:15
Last Modified:	05 Dec 2022 15:52
Publisher DOI:	10.1093/hmg/ddab196
PubMed ID:	34254124
URI:	https://boris.unibe.ch/id/eprint/158014